SELADELPAR LYSINE - Food and Drug Administration
- Set ID
- 7d503c8f-e46a-4695-bae6-7820fdc97e85
- Type
- Indexing - product concept
- Effective date
- 2025-03-17
- Version
- 1
- Source
- DailyMed source
Mapped DailyMed Labels#
| Label | Relation | Manufacturer | Effective |
|---|---|---|---|
| These highlights do not include all the information needed to use LIVDELZI safely and effectively. See full prescribing information for LIVDELZI. LIVDELZI ® (seladelpar) capsules, for oral use Initial U.S. Approval: 2024 | Product name | Gilead Sciences, Inc | 2026-02-03 |
| These highlights do not include all the information needed to use LIVDELZI safely and effectively. See full prescribing information for LIVDELZI. LIVDELZI ® (seladelpar) capsules, for oral use Initial U.S. Approval: 2024 | Product name | Gilead Sciences, Inc | 2025-10-14 |
| These highlights do not include all the information needed to use LIVDELZI safely and effectively. See full prescribing information for LIVDELZI. LIVDELZI ® (seladelpar) capsules, for oral use Initial U.S. Approval: 2024 | Product name | Gilead Sciences, Inc | 2024-08-14 |